30 closest matches · ranked by relevance
Pulmonary Cystic Fibrosis
Primary: Absolute Change in FEV1 % Predicted From Visit 1 to Visit 3 Between ERR-10 Day and ERR-14 Day — 13.30; 13.83 percentage change — p=0.0164
Non-Cystic Fibrosis Bronchiectasis
Primary: Bacterial Clearance Rate of Sputum — 38; 16 Participants
Bronchiectasis
Primary: 24 Hour Sputum Volume — 41.8; 23.6; 29.9; 26.2 gram — p=<0.01
Non-Cystic Fibrosis Bronchiectasis
Primary: Median Number of Exacerbations — 1; 2 exacerbations
Bronchiectasis
Primary: Time to First Exacerbation Event Within 48 Weeks — 336; NA; 186 Days — p=0.0650
Bronchiectasis
Primary: Change in QOL-B Respiratory Symptoms Score at Day 28 — 7.4; 5.7 units on a scale — p=0.68
Bronchiectasis
Primary: Change in QOL-B Respiratory Symptoms Score at Day 28 — 8.2; 3.2 units on a scale — p=0.011
Bronchiectasis With Acute Exacerbation
Primary: Bronchiectasis Exacerbation — 0.98; 0.75 proportion of acute exacerbations
Bronchiectasis
Primary: Time to First Exacerbation Event Within 48 Weeks - Cipro 28 vs. Pooled Placebo — NA; NA Days — p=0.0511
Chronic Obstructive Pulmonary Disease
Primary: Number of Patients Who Were Cured — 91; 117 Participants — p=<0.05
Chronic Bronchitis
Primary: Percentage of Clinical Cure (Success) at Test of Cure Visit(Clinical Per Protocol Population) — 93.0; 94.2; 7.0; 5.8 percent
Non-Cystic Fibrosis Bronchiectasis
Primary: Annualized Rate of Pulmonary Exacerbations (PEs) — 1.015; 1.036; 1.286 exacerbation per participant-year — p==0.0019
Non-Cystic Fibrosis Bronchiectasis
Primary: Time to the First Pulmonary Exacerbation Over 24-Week Treatment Period — NA; NA; 189.0 days — p== 0.014
Bronchiectasis
Primary: Nontuberculous Mycobacterial (NTM) Disease — 188; 32 Events — p=0.19
Bronchiectasis
Primary: Change From Baseline in Total Bacterial Load in the Sputum at End of Treatment (Day 29). — -2.94; -0.32 log10 of CFU per gram sputum — p=< 0.001
Bronchiectasis
Primary: Reliability of the Respiratory Domain of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) — 0.80 Intraclass Correlation Coefficient
Chronic Obstructive Pulmonary Disease
Primary: Exacerbation Rate — 1.20; 1.31 exacerbation per patient year — p=0.7282
Bronchiectasis
Primary: Rate of Graded Pulmonary Exacerbations — 1.95; 2.10; 1.69; 1.84 GPE events per year — p=0.3115
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in FEV1 to Day 7 - ITT Population — 0.084; 0.115; 0.057 litre — p=0.012
Bronchitis
Primary: St. George's Respiratory Questionnaire (SGRQ) Scores at Baseline and End of Treatment — 69.6; 67.4; 61.0; 64.5 units on a scale
Chronic Obstructive Pulmonary Disease (COPD)
Primary: Time to the Next COPD Exacerbation — 72; 58 days — p=0.764
Non-cystic Fibrosis Bronchiectasis · Pseudomonas Aeruginosa · Lung Infection
Primary: P. Aeruginosa Recovery in Sputum Following Multiple Doses of AP-PA02 Administered by Inhalation — -0.5; -0.1; -0.4; 1.0 colony forming units log10
Chronic Obstructive Pulmonary Disease
Primary: Length of Stay — 4.8; 3.2 days
Copd
Primary: Number of PRN Respiratory Therapy Drugs Per Day (PRN Treatments With Short Acting Bronchodilators Via Nebulization Given by Respiratory Therapists). — 0.03 treatments…
Chronic Obstructive Pulmonary Disease
Primary: To Evaluate the Rate of Severe Exacerbations in COPD, Comparing COPD Patients Previously Treated According to the PRO-CT Protocol Versus COPD Patients Previously Treated…
Respiratory Disorders
Primary: Percentage of Sputum Samples Positive for Bacterial Pathogens as Identified by Bacteriological Methods, in Any Stable COPD Patients and During AECOPDs — 74.2; 78; 94.6…
Obliterative Bronchiolitis
Primary: Per Cent Change of Forced Expiratory Volume in 1 Second (FEV1) After Bronchodilators — 14; 7 per cent positive change
COPD Exacerbation
Primary: Change in Lung Function (Forced Expiratory Volume in 1 Second (FEV1) — 15.2; 20.1 percentage of change in FEV1
Cystic Fibrosis
Primary: Change in FEV1 — -0.07; -0.08 Liters
Cystic Fibrosis
Primary: Time to an Exacerbation — 58; 51.5 Days — p=0.0715